Okay, let's tackle this question. The user wants to know which opioid shouldn't be used with MAO inhibitors. First, I need to recall the core concept here. MAO inhibitors block the breakdown of neurotransmitters like serotonin and norepinephrine. Using certain opioids with them can lead to serotonin syndrome, a dangerous condition.

Now, which opioids are involved? I remember that meperidine (pethidine) is a known culprit because it's metabolized into normeperidine, which has serotonergic activity. Other opioids like morphine or fentanyl might not have this issue. So the correct answer is likely meperidine.

Looking at the options, if the correct answer is option C, then I need to explain why meperidine is the one to avoid. The other options (maybe morphine, fentanyl, hydromorphone) aren't associated with serotonin syndrome when combined with MAOIs.

Wait, I should double-check if other opioids like tramadol are also a concern. Tramadol can increase serotonin levels, but maybe it's not on the list here. The key is that meperidine's metabolite is the main issue.

For the clinical pearl, emphasizing that meperidine should be avoided with MAOIs to prevent serotonin syndrome is crucial. Also, mentioning the risk factors like high doses or prolonged use could be helpful.

Now, structuring the explanation: start with the core concept about MAOIs and serotonin. Then explain meperidine's metabolism leading to normeperidine. Then go through each incorrect option, stating why they don't cause the same issue. Finally, the clinical pearl as a takeaway. Make sure the answer is concise and fits within the character limit.

**Core Concept**
The interaction between monoamine oxidase inhibitors (MAOIs) and certain opioids arises from serotonin syndrome risk. MAOIs inhibit serotonin metabolism, while opioids like meperidine produce metabolites (e.g., normeperidine) that enhance serotonergic activity. This combination can lead to life-threatening hyperthermia, seizures, and neuromuscular excitation.

**Why the Correct Answer is Right**
Meperidine (pethidine) is metabolized to normeperidine, a central nervous system stimulant with serotonergic effects. When combined with MAOIs, normeperidine accumulates due to inhibited breakdown, causing excessive serotonin activity. This synergistic effect triggers serotonin syndrome, characterized by confusion, tachycardia, and muscle rigidity. Other opioids (e.g., morphine, fentanyl) lack this metabolic pathway and are safer in this context.

**Why Each Wrong Option is Incorrect**
**Option A:** Morphine does not produce serotonergic metabolites and is not contraindicated with MAOIs.
**Option B:** Fentanyl has minimal serotonergic activity and no significant interaction with MAOIs.
**Option D:** Hydromorphone lacks the metabolic profile to cause serotonin syndrome in MAOI users.

**Clinical Pearl / High-Yield Fact**
**Meperidine (pethidine)** is the only opioid explicitly contraindicated with MAOIs. Remember: *“Meperidine + MAOI = Serotonin Syndrome.”* Always avoid this combination in clinical practice, especially in postoperative or psychiatric settings where MAOIs may be used.

**Correct Answer: C.

✓ Correct Answer: D. Pethidine